United States - English - NLM (National Library of Medicine)

a-s medication solutions - ipratropium bromide (unii: j697uz2a9j) (ipratropium - unii:gr88g0i6ul) - ipratropium bromide anhydrous 0.5 mg in 2.5 ml - ipratropium bromide inhalation solution administered either alone or with other bronchodilators, especially beta adrenergics, is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. ipratropium bromide is contraindicated in known or suspected cases of hypersensitivity to ipratropium bromide, or to atropine and its derivatives. ipratropium bromide inhalation solution 0.02% read complete instructions carefully before using. - twist open the top of one unit dose vial and squeeze the contents into the nebulizer reservoir. (figure 1). - connect the nebulizer reservoir to the mouthpiece or face mask (figure 2). - connect the nebulizer to the compressor. - sit in a comfortable, upright position; place the mouthpiece in your mouth (figure 3) or put on the face mask and turn on the compressor. if a face mask is used, care should be taken to avoid leakage around the mask as temporary blu

Canada - English - Health Canada

juno pharmaceuticals corp. - ipratropium bromide (ipratropium bromide monohydrate); salbutamol (salbutamol sulfate) - solution - 0.5mg; 2.5mg - ipratropium bromide (ipratropium bromide monohydrate) 0.5mg; salbutamol (salbutamol sulfate) 2.5mg - antimuscarinics antispasmodics

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - ipratropium bromide monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - ipratropium bromide monohydrate -

United States - English - NLM (National Library of Medicine)

cobalt laboratories, inc. - ipratropium bromide (unii: j697uz2a9j) (ipratropium cation - unii:gr88g0i6ul) - solution - 0.5 mg in 2.5 ml - ipratropium bromide inhalation solution administered either alone or with other bronchodilators, especially beta adrenergics, is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. ipratropium bromide is contraindicated in known or suspected cases of hypersensitivity to ipratropium bromide, or to atropine and its derivatives.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ipratropium bromide monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ipratropium bromide monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - ipratropium bromide, quantity: 0.6 mg/ml - spray, solution - excipient ingredients: sodium hydroxide; sodium chloride; hydrochloric acid; disodium edetate; purified water; benzalkonium chloride - for the symptomatic relief of rhinorrhoea associated with allergic and non-allergic perennial rhinitis, and the common cold.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - ipratropium bromide, quantity: 0.3 mg/ml - spray, solution - excipient ingredients: sodium hydroxide; disodium edetate; hydrochloric acid; purified water; benzalkonium chloride; sodium chloride - symptomatic relief of rhinorrhoea associated with allergic and non-allergic perennial rhinitis. indications as at 28 april 1999: for the symptomatic relief of rhinorrhoea associated with allergic and non-allergic perennial rhinitis, and the common cold.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - ipratropium bromide monohydrate, quantity: 522 microgram (equivalent: ipratropium bromide, qty 500 microgram) - inhalation, conventional - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - for moderate asthma attacks; chronic forms of asthma; asthma in patients with diminished cardiac reserve; chronic obstructive bronchitis with bronchospasm; bronchospasm during or after surgery; use during assisted ventilation with a respirator.